1028P Preliminary phase I results from a first-in-human study of EMB-02, a PD-1xLAG-3 bispecific antibody, in patients (pts) with advanced solid tumors

Autor: Day, D., Ganju, V., Chung, K., Si, L., Mao, L., Aghmesheh, M., Hoyer, R., Brewin, K., Zeng, S., Lu, Q., Jiang, C., Ren, F., Wu, X., Guo, J.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S625-S625
Databáze: ScienceDirect